FrancophonIA/ELRC3.0 huggingface dataset:
English: Uncommonly reported side effects: bacterial infection, feeling of pins and needles, and pericarditis (inflammation of the lining of the heart).
Danish: Ikke almindelige bivirkninger: bakterieinfektion, en prikkende og stikkende fornemmelse og perikarditis (betændelse i hjertesækken).
English: This risk should be weighed against the disease characteristics of the child, such as evidence of disease progression (notably fibrosis), co-morbidities that may negatively influence the disease progression (such as HIV co-infection), as well as prognostic factors of response, (HCV genotype and viral load).
Danish: (især fibrose), co-morbiditet der kan have en negativ virkning på sygdomsudviklingen (såsom hiv co-infektion) såvel som prognostiske faktorer på respons (HCV-genotype og virusbelastning).
English: The efficacy and safety of IntronA in combination with ribavirin has been studied in children and adolescents who have not been previously treated for chronic hepatitis C.
Danish: Virkning og sikkerhed ved IntronA i kombination med ribavirin er blevet undersøgt hos børn og unge, der ikke tidligere har været behandlet for kronisk hepatitis C.
English: Liver graft rejection has also been reported.
Danish: Afstødning efter levertransplantation er også rapporteret.
English: - if you have a history of seizures (convulsions).
Danish: - hvis du tidligere har haft anfald (kramper).
English: SVR after treatment of chronic HCV with non-pegylated interferon alfa-2b (with or without ribavirin) results in long-term clearance of the virus providing resolution of the hepatic infection and clinical 'cure' from chronic HCV.
Danish: SVR efter behandling af kronisk HCV med ikke pegyleret interferon alfa-2b (med eller uden ribavirin) resulterer i langtidsclearance af virus, hvilket medfører resolution af den hepatiske infektion og klinisk 'helbredelse' af kronisk HCV.
English: Table 2 Adverse reactions very commonly and commonly reported during clinical trials in children and adolescent patients treated with IntronA in combination with ribavirin
Danish: Tabel 2 Bivirkninger rapporteret som værende meget almindelige eller almindelige i kliniske undersøgelser hos børn og unge behandlet med IntronA i kombination med ribavirin Systemorganklasser
English: Any unused medicinal product must be discarded after withdrawal of the dose and in accordance with local requirements.
Danish: Ikke anvendt lægemiddel samt affald heraf skal bortskaffes i henhold til lokale retningslinjer.
English: 25 million IU/2.5 mL
Danish: 25 millioner IE/2,5 ml
English: Inject the solution by pushing the plunger all the way down gently (Diagram C).
Danish: Injicer opløsningen ved blidt at trykke stemplet helt i bund (Diagram C).
English: IntronA 25 MIU
Danish: IntronA 25 MIE
English: Dental and gum disorders, which may lead to loss of teeth, have been reported in patients receiving IntronA and ribavirin combination therapy.
Danish: Tand- og tandkødslidelser, som kan lede til tab af tænder, er blevet rapporteret hos patienter, der fik IntronA og ribavirin kombinationsbehandling.
English: IntronA is used in combination with ribavirin in children 3 years of age and older and adolescents who have previously untreated chronic hepatitis C.
Danish: IntronA anvendes i kombination med ribavirin hos børn i alderen 3 år eller ældre og unge, som har tidligere ubehandlet kronisk hepatitis C.
English: Dental and periodontal disorders, which may lead to loss of teeth, have been reported in patients receiving IntronA and ribavirin combination therapy.
Danish: Dentale og parodontale lidelser, som kan føre til tab af tænder, er blevet rapporteret hos patienter, der fik IntronA og ribavirin kombinationsbehandling.
English: Hepatic function abnormal
Danish: Unormal lever funktion
English: Disodium phosphate anhydrous Sodium dihydrogen phosphate monohydrate Edetate disodium
Danish: Dinatriumphosphat vandfri Natriumdihydrogenphosphatmonohydrat Dinatriumedetat
English: Your doctor or his/her assistant will instruct you how to selfinject IntronA.
Danish: Læs venligst vejledningerne omhyggeligt og følg dem trin for trin. Din læge eller hans/hendes assistent vil instruere dig i, hvordan du selv injicerer IntronA.
English: Preclinical juvenile toxicity results have demonstrated a minor, dose-related decrease in overall growth in neonatal rats dosed with ribavirin (see section 5.3 of Rebetol SPC if IntronA is to be administered in combination with ribavirin).
Danish: Prækliniske toksicitetsresultater i unge dyr viste en mindre dosisrelateret nedsættelse i den totale vækst hos neonatale rotter behandlet med ribavirin (se pkt.
English: Immediately contact the doctor or seek emergency treatment if they display any unusual behavioural symptoms, feel depressed, or feel they want to harm themselves or others.
Danish: Pårørende til børn og unge skal straks kontakte læge eller skadestue, hvis de bemærker nogen som helst tegn på usædvanlig opførsel, depression eller aggressiv adfærd rettet mod sig selv eller andre.
English: Visually confirm the pushrod has fully advanced and the needle tip is covered.
Danish: Se efter, om trykstangen er helt fremme, og kanylespidsen er dækket.
English: - The use of interferon alfa-2b in children and adolescents with existence of or history of severe psychiatric conditions is contraindicated (see section 4.3).
Danish: - Brug af interferon alfa-2b hos børn og unge med aktuelle eller tidligere alvorlige psykiatriske lidelser er kontraindiceret (se pkt.
English: Pack of 2 vials
Danish: Pakning a 2 hætteglas
English: Possible side effects listed below are grouped by frequency of occurrence: Very common (affects more than 1 user in 10) Common
Danish: Mulige bivirkninger er anført nedenfor og grupperet efter hyppighed: Meget almindelig
English: - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Danish: - Overfølsomhed over for det (de) aktive stof(fer) eller over for et eller flere af hjælpestofferne anført i pkt.
English: - The other ingredients are disodium phosphate anhydrous, sodium dihydrogen phosphate monohydrate, edetate disodium, sodium chloride, m-cresol, polysorbate 80 and water for injections.
Danish: - Øvrige indholdsstoffer: Dinatriumphosphat vandfri, natriumdihydrogenphosphatmonohydrat, dinatriumedetat, natriumchlorid, m-cresol, polysorbat 80 og vand til injektionsvæsker.
English: IntronA is administered subcutaneously at a dose of 3 million IU three times a week (every other day) to adult patients, whether administered as monotherapy or in combination with ribavirin.
Danish: IntronA indgives subkutant i en dosis på 3 millioner IE tre gange om ugen (hver anden dag) til voksne patienter, både anvendt som monoterapi og i kombination med ribavirin.
English: Periodontal (affecting gums) and dental disorders, change in colour of the tongue, altered mental status, loss of consciousness, acute hypersensitivity reactions including urticaria (hives), angioedema (swelling of the hands, feet, ankles, face, lips, mouth, or throat which may cause difficulty in swallowing or breathing), bronchoconstriction and anaphylaxis (a severe, whole-body allergic reaction) have been reported, but their frequency is unknown.
Danish: Ikke kendte bivirkninger: periodontal (lidelse som påvirker gummerne) og tandlidelser, ændring i tungens farve, ændring i mental tilstand, tab af bevidsthed, akutte overfølsomhedsreaktioner inklusive urticaria (udslæt), angioødem (hævelse af hænder, fødder, ankler, ansigt, læber, mund eller hals, som kan medføre synkebesvær eller besværet vejrtrækning), bronkokonstriktion og anafylakse (en kraftig allergisk reaktion over hele kroppen) har været rapporteret, men hyppigheden er ukendt.
English: The usual dose is 5 million IU (3 to 9 million IU) administered subcutaneously three times a week (every other day).
Danish: Den sædvanlige dosis er 5 millioner IE (3 til 9 millioner IE) givet subkutant tre gange om ugen (hver anden dag).
English: Diarrhoea, vomiting, nausea, abdominal pain Mouth ulceration, stomatitis ulcerative, stomatitis, right upper quadrant pain, dyspepsia, glossitis, gastroesophageal reflux, rectal disorder, gastrointestinal disorder, constipation, loose stools, toothache, tooth disorder
Danish: Diarré, opkastning, kvalme, mavesmerte Mundsår, ulcerativ stomatitis, stomatitis, smerte i øvre højre kvadrant, dyspepsi, glossitis, gastroøsofageal refluks, rektale forstyrrelser, gastrointestinale forstyrrelser, forstoppelse, løs afføring, tandpine, tandproblemer
English: IntronA is available in twelve different pack sizes:
Danish: IntronA er tilgængelig i tolv forskellige pakningsstørrelser: - Pakning a 1 hætteglas
English: Vertigo, tinnitus Hearing loss, hearing disorder
Danish: Vertigo, tinnitus Høretab, høreforstyrrelser
English: §, asthenia,
Danish: §, mani,
English: Enuresis, micturition disorder, urinary incontinence
Danish: Enuresis, vandladningsproblemer, urininkontinens
English: For example, in a trial of high-dose adjuvant IntronA treatment in patients with melanoma, incidences of fatigue, pyrexia, myalgia, neutropaenia/anaemia, anorexia, nausea and vomiting, diarrhoea, chills, flulike symptoms, depression, alopecia, altered taste, and dizziness were greater than in the hepatitis C trials.
Danish: For eksempel var incidensen af træthed, feber, myalgi, neutropeni/anæmi, anoreksi, kvalme og opkastning, diarré, kulderystelser, influenzalignende symptomer, depression, alopeci, smagsforstyrrelser og svimmelhed i en undersøgelse af højdosis adjuverende IntronA-behandling hos patienter med melanom større end i hepatitis C undersøgelserne.
English: Excipients: disodium phosphate anhydrous, sodium dihydrogen phosphate monohydrate, edetate disodium, sodium chloride, m-cresol, polysorbate 80 and water for injections.
Danish: Hjælpestoffer: dinatriumphosphat vandfri, natriumdihydrogenphosphatmonohydrat, dinatriumedetat, natriumchlorid, m-cresol, polysorbat 80 og vand til injektionsvæsker.
English: Myocardial infarction, cardiac ischaemia Congestive heart failure, pericardial effusion, arrhythmia
Danish: Myokardieinfarkt, hjerteiskæmi Hjerteinsufficiens, perikardieeffusion, arytmi
English: IntronA 3 MIU
Danish: IntronA 3 MIE
English: HCV/HIV Coinfection
Danish: Samtidig infektion med HCV/hiv
English: Rotate the needle protection device for bevel orientation or scale readability.
Danish: Drej kanylehætten for placering af kanylespidsen eller for at kunne læse skalaen.
English: The efficacy of IntronA is enhanced when given in combination with ribavirin.
Danish: Virkningen af IntronA er øget ved indgift i kombination med ribavirin.
English: IntronA treatment may be initiated if TSH levels can be maintained in the normal range by medication.
Danish: IntronA-behandling kan initieres, hvis TSH-niveauet kan fastholdes inden for normalområdet med medicinsk behandling.
English: SVR after treatment of chronic HCV with non-pegylated interferon alfa-2b with ribavirin results in long-term clearance of the virus providing resolution of the hepatic infection and clinical 'cure' from chronic HCV.
Danish: SVR efter behandling af kronisk HCV med ikke-pegyleret interferon alfa-2b med ribavirin resulterede i langtids-clearance af virus, som resulterede i opløsning af den hepatiske infektion og klinisk 'helbredelse' af kronisk HCV.
English: Any thyroid abnormality detected at that time must be treated with conventional therapy.
Danish: Unormal thyroideafunktion på dette tidspunkt bør behandles med konventionel behandling.
English: Each vial contains 10 million IU in 1 mL of solution.
Danish: Hvert hætteglas indeholder 10 millioner IE i 1 ml opløsning.
English: Ocular adverse events (see section 4.8) including retinal haemorrhages, cotton wool spots, serous retinal detachment, and retinal artery or vein obstruction have been reported in rare instances after treatment with alpha interferons.
Danish: 4.8) inklusive nethindehæmoragi, "uldtotter", serøs nethindeløsning og arterie- eller veneokklusion i nethinden er blevet rapporteret i sjældne tilfælde efter behandling med alfa interferoner.
English: Relapse patients
Danish: Relaps-patienter
English: Check with your doctor immediately if any of the following side effects occur: - chest pain or persistent and severe cough; irregular or rapid heartbeat; shortness of breath, confusion, difficulty remaining alert, numbness or tingling sensation or pain in hands or feet; seizure (convulsions); trouble sleeping, thinking or concentrating; altered mental state; suicidal thoughts, suicide attempt, changed behaviour or aggressive behaviour (sometimes directed against others), hallucinations; severe stomach pain; black or tar like stools; blood in stool or urine, severe nosebleed; waxy pallor, high sugar level in blood, fever or chills beginning after a few weeks of treatment, lower back or side pain, difficult urination, problems with your eyes or your eyesight or hearing, loss of hearing, severe or painful reddening or sores on your skin or mucous membrane.
Danish: Kontakt din læge så hurtigt som muligt, hvis en af følgende bivirkninger forekommer: - brystsmerte eller vedvarende og svær hoste; uregelmæssige eller hurtige hjerteslag; åndedrætsbesvær, forvirring, besvær med at forblive opmærksom, følelsesløshed eller prikkende fornemmelse eller smerte i hænder eller fødder; anfald (kramper); besvær med at sove, tænke eller koncentrere sig, ændret mental status; selvmordstanker, selvmordsforsøg, ændret opførsel eller aggressiv opførsel (sommetider rettet mod andre); hallucinationer; kraftig mavesmerte; sorte eller tjærelignende afføringer; blod i afføring eller urin, kraftig næseblod; voksagtig bleghed, højt sukkerniveau i blodet, feber eller kulderystelser begyndende efter få ugers behandling, lavtsiddende ryg- eller sidesmerte, vanskelig vandladning, problemer med dine øjne, syn eller hørelse, høretab, kraftig eller smertefuld rødme eller ømhed på din hud eller slimhinde.
English: Chronic Myelogenous Leukaemia: 4-5 million IU/m 2 daily injected subcutaneously (under the skin).
Danish: Kronisk myeloid leukæmi: 4-5 millioner IE/m 2 daglig injiceret subkutant (under huden).
English: Corresponding dose (million IU) using IntronA 25 million IU/2.5 mL solution for injection or infusion
Danish: Korresponderende dosis (million IE) ved brug af IntronA 25 million IE/2,5 ml injektionsvæske eller infusionsvæske
English: Thrombocytopaenia, lymphadenopathy, lymphopenia Aplastic anaemia
Danish: Trombocytopeni, lymfadenopati, lymfopeni Aplastisk anæmi
English: Corresponding dose (million IU) using IntronA 18 million IU/3 mL solution for injection or infusion
Danish: Korresponderende dosis (million IE) ved brug af IntronA 18 million IE/3 ml injektionsvæske eller infusionsvæske
English: Hyperkinesia, tremor, dysphonia, paresthaesia, hypoaesthesia, hyperaesthesia, concentration impaired, somnolence
Danish: Hyperkinesi, tremor, dysfoni, paræstesi, hypæstesi, hyperæstesi, koncentrationsbesvær, søvnighed
English: Rhabdomyolysis, myositis, leg cramps, back pain
Danish: Rabdomyolyse, myositis, benkramper, rygsmerte
English: IntronA 5 MIU
Danish: IntronA 5 MIE
English: In the presence of thyroid dysfunction, IntronA treatment may be continued if TSH levels can be maintained in the normal range by medication.
Danish: I tilfælde af thyroideadysfunktion kan IntronA-behandling fortsættes, hvis TSHkoncentrationen kan holdes i normalområdet ved relevant behandling.
English: Patients with pre-existing cardiac abnormalities
Danish: Patienter med præ-eksisterende hjerteanomalier
English: §, rash maculopapular, rash erythematous, eczema, erythema, skin disorder Stevens Johnson syndrome, toxic epidermal necrolysis, erythema multiforme
Danish: §, makulopapuløst udslæt, erytematøst udslæt, eksem, erytem, hudlidelser Stevens-Johnsons syndrom, toksisk epidermal nekrolyse, erythema multiforme
English: Chronic myelogenous leukaemia The recommended dose of IntronA is 4 to 5 million IU/m2 administered daily subcutaneously.
Danish: Den anbefalede dosering af IntronA er 4 til 5 millioner IE/m2 givet dagligt subkutant.
English: Anaemia, neutropaenia Thrombocytopaenia, lymphadenopathy
Danish: Anæmi, neutropeni Trombocytopeni, lymfadenopati
English: Pack of 12 vials, 72 injection syringes with attached needle of 1 mL and 144 cleansing swabs Not all pack sizes may be marketed.
Danish: Pakning a 12 hætteglas, 72 injektionssprøjter a 1 ml med påsat kanyle og 144 renseservietter Ikke alle pakningsstørrelser er nødvendigvis markedsført.
English: Current clinical experience indicates that maintenance therapy with interferon alfa-2b prolongs the plateau phase; however, effects on overall survival have not been conclusively demonstrated.
Danish: Nuværende kliniske erfaringer indikerer, at vedligeholdelsesbehandling med interferon alfa-2b forlænger plateaufasen.
English: 5 million IU/0.5 mL
Danish: 5 millioner IE/0,5 ml
English: Dilute prior to intravenous use.
Danish: Fortyndes før intravenøs anvendelse.
English: Photosensitivity reaction, maculopapular rash, eczema, acne, skin disorder, nail disorder, skin discolouration, pruritus, dry skin, erythema, bruise, sweating increased
Danish: Fotosensitivitets reaktioner, makulopapuløst udslæt, eksem, akne, hudlidelse, neglelidelse, pigmentforandringer, pruritus, tør hud, erythem, blå mærker, øget svedtendens
English: Commonly reported side effects: thirst, dehydration, high blood pressure, migraines, swollen glands, flushing, menstrual problems, decreased sexual drive, vaginal problem, breast pain, pain in testicle, problems with thyroid gland, red gums, dry mouth, red or sore mouth or tongue, tooth ache or tooth disorder, herpes simplex (fever blisters), taste change, upset stomach, dyspepsia (heartburn), constipation, enlargement of liver (liver problems, sometimes severe), loose stools, bedwetting in children, inflammation of the sinuses, bronchitis, eye pain, problem with your tear ducts, conjunctivitis (“pink eye”), agitation, sleepiness, sleepwalking, problem with behaviour, nervousness, stuffy or runny nose, sneezing, rapid breathing, pale or reddened skin, bruising, problem with skin or nails, psoriasis (new or worsened), increased sweating, increased need to pass urine, fine shaking movements, decreased sensitivity to touch, arthritis.
Danish: Almindelige bivirkninger: tørst, dehydrering, højt blodtryk, migræne, opsvulmede kirtler, rødmen, menstruationslidelser, nedsat seksuallyst, vaginallidelse, brystsmerte, testikelsmerte, skjoldbruskkirtel-lidelser, rødt tandkød, mundtørhed, rødme eller ømhed af mund eller tunge, tandpine eller tandlidelse, forkølelsessår (herpes simplex), ændret smagsopfattelse, mavetilfælde, halsbrand (dyspepsi), forstoppelse, forstørret lever (leverlidelser, undertiden alvorlige), løse afføringer, sengevædning hos børn, bihulebetændelse, bronkitis, øjensmerte, problemer med dine tårekanaler, konjunktivitis ("røde øjne"), uro, søvnighed, søvngængeri, adfærdsproblemer, nervøsitet, tæt eller løbende næse, nysen, hurtigt åndedræt, bleg eller rødmende hud, blå mærker, hud- eller negleproblemer, psoriasis (ny eller forværret), øget svedtendens, øget vandladningstrang, let rysten, nedsat følsomhed ved berøring, gigt.
English: IntronA 10 MIU
Danish: IntronA 10 MIE
English: - Autoimmune hepatitis; or history of autoimmune disease; immunosuppressed transplant recipients.
Danish: - Autoimmun hepatitis eller tidligere autoimmun sygdom.
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.
Danish: Yderligere oplysninger om IntronA findes på Det Europæiske Lægemiddelagenturs hjemmeside http://www.ema.europa.eu.
English: Children 3 years of age and older and adolescents IntronA is indicated, in a combination regimen with ribavirin, for the treatment of children 3 years of age and older and adolescents, who have chronic hepatitis C, not previously treated, without liver decompensation, and who are positive for HCV-RNA.
Danish: IntronA er - i kombination med ribavirin - indikeret til behandling af børn i alderen 3 år eller ældre samt unge, som lider af tidligere ubehandlet kronisk hepatitis C uden leverdekompensation, og som er positive for HCV-RNA.
English: 3 million IU/0.5 mL
Danish: 3 millioner IE/0,5 ml
English: Very commonly reported side effects: pain, swelling and redness or skin damage at site of injection, hair loss, dizziness, changes in appetite, stomach or abdominal pains, diarrhoea, nausea (feeling sick), viral infection, depression, emotional lability, insomnia, anxiety, sore throat and painful swallowing, fatigue, chills/rigors, fever, flu-like reaction, feeling of general discomfort, headaches, weight loss, vomiting, irritability, weakness, mood swings, coughing (sometimes severe), shortness of breath, itching, dry skin, rash, sudden and severe muscle pain, joint pain, musculoskeletal pain, changes in laboratory blood values including decreased white blood cell count.
Danish: Meget almindelige bivirkninger: smerte, hævelse og rødme eller hudskade på injektionsstedet, hårtab, svimmelhed, ændret appetit, mave- eller abdominalsmerter, diarré, kvalme (følelse af at være syg), virusinfektion, depression, emotionel ustabilitet, søvnløshed, angst, ondt i halsen og smertefuld synken, træthed, kulderystelse/stivhed, feber, influenzalignende reaktion, følelse af generelt ubehag, hovedpine, vægttab, opkastning, irritabilitet, svaghed, humørsvingninger, hoste (i nogle tilfælde kraftig), kortåndethed, kløe, tør hud, udslæt, pludselig og kraftig muskelsmerte, ledsmerter, smerte i bevægeapparatet, ændringer i laboratorieblodværdier inklusive nedsat antal hvide blodlegemer.
English: Epistaxis, respiratory disorder, nasal congestion, rhinorrhea, cough nonproductive Pulmonary infiltrates
Danish: Epistaxis, respiratorisk forstyrrelse, forstoppet næse, rinoré, hoste uden slim
English: The appropriate dose of IntronA is withdrawn from the vial(s), added to 50 mL of 9 mg/mL (0.9 %) sodium chloride solution for injection in a PVC bag or glass bottle for intravenous use and administered over 20 minutes.
Danish: Den beregnede mængde IntronA trækkes op af hætteglasset (glassene), tilsættes til 50 ml 9 mg/ml (0,9 %) natriumchlorid injektionsvæske i en PVC pose eller glasflaske til intravenøs anvendelse og indgives over 20 minutter.
English: Injection site inflammation, injection site reaction*, fatigue, rigors, pyrexia
Danish: Inflammation på injektionsstedet, reaktion på injektionsstedet*, træthed, stivhed, feber
English: Pericarditis
Danish: Perikarditis
English: At the discretion of the physician, the patient may self-administer the dose for maintenance dose regimens administered subcutaneously.
Danish: Ved subkutan dosering i forbindelse med vedligeholdelsesbehandling kan lægen beslutte, om patienten selv kan injicere dosis.
English: Follicular lymphoma: Adjunctively with chemotherapy, 5 million IU 3 times a week (every other day) injected subcutaneously (under the skin).
Danish: Follikulært lymfom: Supplerende til kemoterapi, 5 millioner IE 3 gange om ugen (hver anden dag) injiceret subkutant (under huden).
English: One vial contains 18 million IU of interferon alfa-2b in 3 mL of solution.
Danish: Et hætteglas indeholder 18 millioner IE interferon alfa-2b i 3 ml opløsning.
English: Collect necessary items before you begin: - a vial of IntronA solution for injection; - a syringe with an attached needle for subcutaneous injection; - a cleansing swab.
Danish: Saml det nødvendige udstyr, før du begynder: - et hætteglas med IntronA injektionsvæske, opløsning, - en sprøjte med påsat kanyle til subkutan injektion, - en renseserviet.
English: Myalgia, arthralgia, musculoskeletal pain Arthritis
Danish: Myalgi, artralgi, smerter i bevægeapparatet Artritis
English: 18 million IU/3 mL solution for injection or infusion 1 multiple dose vial
Danish: 18 millioner IE/3 ml injektionsvæske eller til infusionsvæske 1 flerdosis hætteglas
English: §, optic neuritis, papilloedema, loss of visual acuity or visual field, cottonwool spots
Danish: §, optisk neuritis, papilødem, tab af synsskarphed eller synsfelt, slørede pletter Serøs nethindeløsning
English: Each vial contains 5 million IU in 0.5 mL of solution.
Danish: Hvert hætteglas indeholder 5 millioner IE i 0,5 ml opløsning.
English: HOW TO SELF INJECT INTRONA Syringe with an unattached needle
Danish: SÅDAN INJICERER DU SELV INTRONA Injektionssprøjte uden påsat nål